Firstly, insulin resistance leads to hyperinsulinemia, which in turn motivates signaling pathways (Ras/MAPK and PI3K/Akt/mTOR), NF-κB nuclear translocation, and gene transcription from cancer-related genes. The gene discussed is AKT1; the disease is Hyperinsulinemia.